Award

NIH Reporter #1F31HL182293-01

CFTR gene correction via targeted exon replacement

Recipient

University of Texas at Austin

Award Amount

$41,057.00

Ceiling

$41,057.00

Awarded

September 03, 2025

Identifier

1F31HL182293-01

The project will investigate a gene-editing strategy intended to safely and efficiently replace CFTR exon 12, with the potential to provide a treatment for people with cystic fibrosis who lack therapeutic options.

Description

Project to develop retron editing to replace the entire CFTR exon 12 without creating a DNA break, potentially addressing cystic fibrosis mutations that do not respond to approved CFTR modulators.

View original record